87627-02-9 Usage
Uses
Used in Pharmaceutical Applications:
[2-(furan-2-yl)-4-oxo-4H-chromen-8-yl]acetic acid is used as a pharmaceutical compound for its potential therapeutic applications. The antioxidant, anti-inflammatory, and antimicrobial properties of this chemical make it a promising candidate for the development of new drugs targeting various health conditions.
Used in Fragrance and Flavor Industry:
In the fragrance and flavor industry, [2-(furan-2-yl)-4-oxo-4H-chromen-8-yl]acetic acid is used as a key ingredient for its sweet, vanilla-like odor. This characteristic makes it a valuable addition to the creation of various scents and flavors, enhancing the sensory experience of consumer products.
Used in Organic Synthesis:
[2-(furan-2-yl)-4-oxo-4H-chromen-8-yl]acetic acid is also used as a building block in the synthesis of other organic compounds. Its unique structure allows for the development of new molecules with potential applications in various fields, including materials science, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 87627-02-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,6,2 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 87627-02:
(7*8)+(6*7)+(5*6)+(4*2)+(3*7)+(2*0)+(1*2)=159
159 % 10 = 9
So 87627-02-9 is a valid CAS Registry Number.
87627-02-9Relevant academic research and scientific papers
Synthesis and antitumour activity of new derivatives of flavone-8- acetic acid (FAA). Part 31): 2-Heteroaryl derivatives
Aitken, R. Alan,Bibby, Michael C.,Bielefeldt, Florian,Double, John A.,Laws, Andrea L.,Mathieu, Anne-Laure,Ritchie, Robert B.,Wilson, David W. J.
, p. 405 - 411 (2007/10/03)
A range of 14 derivatives of flavone-8-acetic acid (FAA) with a heterocyclic substituent in place of the 2-phenyl group have been prepared and their anti-tumour activity evaluated in vitro against a panel of human and murine tumour cell lines and in vivo against MAC 15A. Some of the compounds, notably 2c,d and s, showed significant in vivo activity and these require further studies in order to evaluate their potential for development.
